Get all your news in one place.

100's of premium titles.
One app.

Get all your news in one place.

100's of premium titles. One news app.

FOUND: 21 - What They Never Told You

Pfizer and KIMS Hospital launch Center of Excellence for adult vaccination

Pfizer & KIMS Hospital in Hyderabad inaugurated a CoE for Adult Vaccination to equip HCPs & educate patients on enduring advantages of vaccinations. It will reinforce immunisation against Pneumococcal, Hepatitis A/B, HPV & Influenza. CoE symbolises commitment to protecting individuals against respiratory threats & enhancing quality of life.

The Hindu

Company bosses and workers grapple with the fallout of speaking up about the Israel-Hamas war

The fallout from the Israel-Hamas war has spilled into workplaces everywhere, with corporate leaders from the highest ranks of prominent companies weighing in with their views while workers complain their voices are not being heard

The Independent UK

Pfizer doubling cost of Paxlovid

One of the most effective treatments for COVID is going to get a lot more expensive, but Pfizer insists it's fine

Salon

From analysis to the latest developments in health,
read the most diverse news in one place.

Why is Covid-19 Still Affecting the Healthcare Industry?

Back in May, the World Health Organization declared an end to the global Public Health Emergency for Covid-19. Despite the end of the pandemic, however, the healthcare industry is still feeling its effects. Vaccine makers and pharmacy chains are seeing a steep decline in the number of people getting Covid...

Barchart

Beyond COVID vaccines: what else could mRNA technology do for our health?

Many people first became familiar with the term “mRNA” when Pfizer’s and Moderna’s COVID vaccines were rolled out. In the simplest terms, mRNA, which stands for messenger ribonucleic acid, is a type of genetic material that gives cells in our bodies instructions to make specific proteins.

The Conversation

Pfizer cuts full-year outlook due to declining sales of Covid-19-related products

Shares of Pfizer are falling before the opening bell as the company cut its full-year outlook, citing declining sales of its COVID-19-related products

The Independent UK

Pfizer CEO Albert Bourla wants to tap 'Chinese science' as the drug company looks for a new target after COVID

Bourla hopes to bring the same speed in developing a COVID vaccine to discovering new cancer treatments.

Fortune

Read news from The Economist, FT, and more,
with one subscription

Modern companies need a purpose. Execs share advice

“It’s so incredibly powerful [to] have a very clear sense of your objectives.” Angela Hwang, Pfizer’s chief commercial officer said during a MPW panel.

Fortune

Minneapolis Radio Station Trolls Taylor Swift, Travis Kelce With Billboard Before Chiefs-Vikings

Minnesota knew what audience to tailor to, no pun intended.

Sports Illustrated

Chiefs’ Travis Kelce Responds to Aaron Rodgers’s ‘Mr. Pfizer’ Jab

“Who knew I’d get into the vax wars with Aaron Rodgers, man?”

Sports Illustrated

Updated COVID-19 shot slowly rolls out in Texas, but access is spotty

Doses aren’t arriving at providers’ offices at uniform, predictable intervals. Shipments are largely dependent on individual providers’ ability to work out the logistics of ordering, stocking, training and paperwork.

The Texas Tribune

Travis Kelce’s Rumored Romance With Taylor Swift Boosts Brand Engagement

Pfizer and Campbell Soup see surge in searches and sales after dating rumors

Zenger

Which Pharma Stock Has More Potential Gains This Month: Pfizer (PFE) or Eli Lilly & Co. (LLY)?

The pharmaceutical industry is poised for sustained long-term growth due to increased investments in drug development and rapid technological advancements. While leading pharma stocks Pfizer (PFE) and Eli Lilly (LLY) stand to benefit, let us analyze which of these giants is poised for more gains this month. Keep reading.

StockNews.com

Novavax COVID-19 vaccine approved

Vaccine uses different technology than Moderna and Pfizer's mRNA targeting strategy

Salon

Get all your
news in one place.

100's of premium titles.
One news app.

Barchart

3 Quality Stocks to Defend Your Portfolio Against October Volatility

The sell-off in the U.S. stock market has deepened in October, and the Dow Jones Industrial Average is now negative for the year. Amid a challenging macro environment, Berkshire Hathaway, Pfizer, and Coca-Cola look like three good defensive stocks to buy.

The Independent UK

US adds another option for fall COVID vaccination with updated Novavax shots

U.S. regulators have added another option for fall COVID-19 vaccination, updated shots made by Novavax

The Hindu

The trouble with a Nobel for mRNA COVID vaccines

The mRNA vaccine story during the COVID-19 pandemic placed an extraordinary premium on altruism on the part of scientists

The Conversation

Tenacious curiosity in the lab can lead to a Nobel Prize – mRNA research exemplifies the unpredictable value of basic scientific research

The 2023 Nobel Prize in physiology or medicine will go to Katalin Karikó and Drew Weissman for their discovery that modifying mRNA – a form of genetic material your body uses to produce proteins – could reduce unwanted inflammatory responses and allow it to be delivered into cells. While the…

Get all your
news in one place.

100's of premium titles.
One news app.

The Independent UK

Years of research laid the groundwork for speedy COVID-19 shots

The Nobel Prize in Medicine has been awarded to two scientists whose work led to mRNA vaccines against COVID-19

The Conversation

Nobel prize in medicine awarded to mRNA pioneers – here's how their discovery was integral to COVID vaccine development

Billions of people around the world have received the Pfizer or Moderna COVID-19 vaccines. The rapid development of these vaccines changed the course of the pandemic, providing protection against the SARS-CoV-2 virus.

The Hindu

Katalin Kariko, scientific maverick who paved way for mRNA vaccines

Katalin Kariko’s pioneering work -- which paved the way for the Pfizer/BioNTech and Moderna Covid-19 vaccines -- has won her the Nobel Prize in Medicine.

The Independent UK

What to know as fall vaccinations against COVID, flu and RSV get underway

Fall vaccination season is in full swing, with health officials urging both an updated COVID-19 shot and flu vaccine for most everyone

Barchart

Is Pfizer Stock a Buy Near 52-Week Lows for Its 5.08% Yield?

Pfizer stock faces a steep patent cliff, but it's taken steps to offset the coming pressures. Will it be enough?

Salon

Hiccups reported in COVID vax rollout

New shots for COVID and RSV are available, if people can actually get them, let alone want them

Barchart

3 Recession-Proof Stocks to Buy Now

Some recent economic data points have revived recession fears, sending equities sharply lower this September. Here are 3 recession-proof stocks that conservative investors can consider now.

1 … 20 21 22 23

People

From analysis to the latest developments in health,
read the most diverse news in one place.

Organisations

The Kansas City Chiefs

Read news from The Economist, FT, and more,
with one subscription

Topics

Dow Jones Industrial Average

Places

Fourteen days free

Download the app

One app. One membership.
100+ trusted global sources.